- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
2. In Schedule 1 to the principal Order (which specifies substances which, if included in medicinal products make, those products prescription only medicines, and exemptions from restrictions on the sale and supply of prescription only medicines)–
(a)in relation to the substance Felbinac, in the entry in column 5, for “ 30g” there is substituted “50g”;
(b)there is inserted in column 1, at the appropriate place in the alphabetical order of the entries in that column, the substance “Levocarnitine”, and, in column 3, in relation to that substance, there is inserted the entry “ For dietary supplementation”; and
(c)there is inserted in column 1, at the appropriate place in the alphabetical order of the entries in that column, each of the following substances–
“Adapalene”
“Altretamine”
“Apraclonidine Hydrochloride”
“Bicalutamide”
“Calcipotriol Hydrate”
“Citalopram Hydrobromide”
“Dorzolamide Hydrochloride”
“Exemestane”
“Ferumoxsil”
“Moexipril Hydrochloride”
“Quinagolide Hydrochloride”
“Sparfloxacin”
“Tizanidine Hydrochloride”
“Valaciclovir Hydrochloride”
“Venlafaxine Hydrochloride”
“Zalcitabine”.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: